AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (August 9, 2007). doi:10.1152/ajpgi.00199.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/4/G692    most recent
00199.2007v2
00199.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gentilcore, D.
Right arrow Articles by Jones, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gentilcore, D.
Right arrow Articles by Jones, K. L.
Submitted on May 4, 2007
Accepted on July 23, 2007

Role of 5-hydroxytryptamine mechanisms in mediating the effects of small intestinal glucose on blood pressure and antropyloroduodenal motility in older subjects

Diana Gentilcore1, Tanya J Little1, Christine Feinle-Bisset1, Melvin Samsom2, Andre JPM Smout2, Michael Horowitz1, and Karen L. Jones1*

1 Medicine, University of Adelaide, Royal Adelaide Hospital, Adelaide, South Australia, Australia
2 Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, Netherlands

* To whom correspondence should be addressed. E-mail: karen.jones{at}adelaide.edu.au.

Postprandial hypotension is an important clinical problem, particularly in the elderly. 5-hydroxytryptamine 3 (5-HT3) mechanisms may be important in the regulation of splanchnic blood flow, blood pressure and in mediating the effects of small intestinal nutrients on gastrointestinal motility. The aims of this study were to evaluate the effects of the 5-HT3 antagonist, granisetron, on the blood pressure (BP), heart rate (HR) and antropyloroduodenal (APD) motility responses to intraduodenal glucose in the healthy elderly. Ten subjects (5M, 5F, aged 65-76 years) received an intraduodenal glucose infusion (3 kcal/min) for 60 minutes (t = 0-60 min), followed by intraduodenal saline for a further 60 minutes (t = 60-120 min) on two days. Granisetron (10µg/kg) or control (saline) was given intravenously at t = -25 min. BP (systolic and diastolic), HR and APD pressures were measured. Pressure waves in the duodenal channel closest ('local') to the infusion site were quantified separately. During intraduodenal glucose, there were falls in systolic and diastolic BP and a rise in HR (P < 0.0001 for all); granisetron had no effect on these responses. Granisetron suppressed the number and amplitude (P < 0.05 for both) of 'local' duodenal pressures during intraduodenal glucose. Otherwise, the effects of intraduodenal glucose on APD motility did not differ between study days. We conclude that in healthy older subjects 5-HT3 mechanisms modulate the 'local' duodenal motor effects of, but not the cardiovascular responses to, small intestinal glucose.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.